ProMIS Neurosciences Inc PMN

Share price should be $5.50

[Gbathat]

https://s27.q4cdn.com/906368049/files/News/2020/Zacks_SCR_Research_08242020_T.PMN_Vandermosten.pdf

$5.50 as present value share price estimated by independent analyst from Sacks Small Cap Research

The valuation method looked at market opportunity and probability of success in capturing that market opportunity to determine a present day market cap and pps.  

Given bitten FDA approval, I think the probability of success for PMN is improving. 

When will the market catch on?

Thanks for sharing that link to the report Mole101

[Thenorth1990]

considering what's outstanding don't you think that target is quite a stretch , Probably after a reverse split. I dont mind getting rich though.

[Gbathat]

Today, perhaps.  After a phase 1 deal announcement, not at all. The global AD therapy market is $25B.  Let's assume PMN is only going to capture 20%, so $5B. At 20% profit margin, they earn $1B. At a p/e of 20, their market cap is then $20B. Their current market cap is $70M, heck, let's round up to $100M to account for pending partnership dilution effect. $20B divided by

[DavidKingCanada]

SP hitting 1.00-1.50 in 2021 is quite possible. Nasdaq Listing also possibe in 1-2 Years.